Business Context and Reporting Period
This Form 6-K filing by Prana Biotechnology Limited (ASX: PBT) reports the results of the Annual General Meeting (AGM) held on November 17, 2016. The registrant is a foreign private issuer based in Australia. The filing incorporates the announcement regarding the voting outcomes of three specific resolutions.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance report detailing AGM voting results rather than a financial statement.
Material Changes and Voting Results
All resolutions presented at the AGM were carried on a show of hands. The detailed proxy vote results are as follows:
- Adoption of Remuneration Report: Passed with 85.34% of valid proxies in favor (41,599,744 for vs. 7,272,103 against).
- Re-election of Director (Mr. Brian Meltzer): Passed with 91.54% of valid proxies in favor (49,993,746 for vs. 6,322,342 against).
- Approval of 10% Placement Issue: Passed with 85.98% of valid proxies in favor (43,481,645 for vs. 10,062,608 against).
Resolutions 1 and 3 were special resolutions requiring a 75% approval threshold, which was achieved for both.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The Chairman exercised discretion on undirected proxies, voting in favor of all resolutions.
Investor Verification Checklist
- Verify the final terms and execution of the approved 10% placement issue.
- Confirm the effective date of Mr. Brian Meltzer's re-election as a director.
- Review the full Remuneration Report adopted by shareholders for details on executive compensation.
- Check subsequent filings for the actual capital raised from the placement issue.